Resources
6 Results (showing 1 - 6)
Results sorted by updated date (oldest first)
Results sorted by updated date (oldest first)
Posted 10/3/2019 (updated 3/25/2024)
Focus Group / Key informant interview sample questions
Posted 3/15/2022 (updated 3/27/2024)
This TIP reviews three Food and Drug Administration-approved medications for opioid use disorder treatment—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support people in recovery.
Posted 7/22/2020 (updated 3/28/2024)
The Data Sharing among Criminal Justice & Behavioral Health Partners: Addressing Data Sharing Agreements & Confidentiality Concerns Webinar was held June 24, 2020. The resources from this webinar are shared below.
Posted 7/24/2020 (updated 3/28/2024)
This final rule makes changes to the Department of Health and Human Services’ (HHS) regulations governing the Confidentiality of Substance Use Disorder Patient Records. These changes were prompted by the need to continue aligning the regulations with advances in the U.S. health care delivery system, while retaining important privacy protections for individuals seeking treatment for substance use disorders (SUDs).
Posted 10/23/2020 (updated 4/3/2024)
The American Society of Addiction Medicine (ASAM) developed this National Practice Guideline for the Treatment of Opioid Use Disorder to provide information on evidence-based treatment of opioid use disorder.
Posted 4/26/2021 (updated 4/10/2024)
A Protocol Using Empirically Supported Behavioral Treatments for People with Psychoactive Stimulant Use Disorders